Cellebrite DI (CLBT) Acquisitions (2021 - 2025)

Cellebrite DI (CLBT) has reported Acquisitions for 3 consecutive years, with -$147.5 million the latest figure, recorded in Q4 2025.

• In Q4 2025, Acquisitions fell 2782.97% year-over-year to -$147.5 million; the TTM figure through Dec 2025 stood at -$164.7 million (down 1467.33% YoY), while the FY2025 annual figure was $147.5 million, up 5265.94% from the prior year.
• Acquisitions came in at -$147.5 million for Q4 2025 at Cellebrite DI, down from $5.5 million in the prior quarter.
• The five-year high for Acquisitions was $29.3 million in Q3 2021, with the low at -$147.5 million in Q4 2025.
• Average Acquisitions over 3 years is -$23.1 million, with a median of -$2.9 million recorded in 2021.
• The largest YoY upside for Acquisitions was 2782.97% in 2025 against a maximum downside of 2782.97% in 2025.
• Year by year, Acquisitions stood at -$20.0 million in 2021, then soared by 127.48% to $5.5 million in 2024, then slumped by 2782.97% to -$147.5 million in 2025.
• According to Business Quant data, Acquisitions over the past three periods registered -$147.5 million, $5.5 million, and -$2.7 million for Q4 2025, Q4 2024, and Q3 2024 respectively.